IL4 and atopic eczema: In a murine model for atopic dermatitis, oral administration of Se suppressed the development of atopic dermatitis-like skin lesions, lowered total IgE levels, reduced skin expression of IL-4 and led to a lower number of mast cells in the skin [36].